New Guidelines for Hypertension Diagnosis and Treatment: An European Perspective
Guido Grassi
doaj +1 more source
Blood Pressure-Lowering Effect of SGLT2 Inhibitors in Patients Without Antihypertensive Treatment: A Real-World Data Analysis. [PDF]
Ito R +12 more
europepmc +1 more source
ABSTRACT The stress hyperglycemia ratio (SHR), a novel marker reflecting relative hyperglycemia, has been increasingly recognized for its prognostic value in cardiovascular and metabolic diseases. However, its association with early renal damage in hypertensive patients remains underexplored.
Kai‐Jun Zhang +5 more
wiley +1 more source
Effects of high-intensity interval training on cardiac function in hypertensive and normotensive men: Effects of antihypertensive treatment. [PDF]
Fischer M +8 more
europepmc +1 more source
ABSTRACT The impacts of cardiometabolic risk factors (CMRFs) and the biomarkers on disease severity in metabolic dysfunction‐associated steatotic liver disease (MASLD) remain elusive. Accordingly, a multicenter study by recruiting MASLD patients from a nationwide registry database was conducted with a total of 2882 MASLD patients (54.1% males, mean age
Jee‐Fu Huang +14 more
wiley +1 more source
Association of frailty with dementia and the impact of frailty on antihypertensive treatment protection against dementia in older hypertensive adults. [PDF]
Chen L +14 more
europepmc +1 more source
ABSTRACT The cardiovascular–kidney–metabolic (CKM) framework and metabolic dysfunction–associated steatotic liver disease (MASLD) describe a shared clinical continuum, but the prognostic value of joint fatty liver index (FLI)–NAFLD fibrosis score (NFS) phenotypes across CKM stages is uncertain.
Yi‐Fei Wang +5 more
wiley +1 more source
Correction: The association between antihypertensive treatment and serious adverse events by age and frailty: A cohort study. [PDF]
Sheppard JP +11 more
europepmc +1 more source
ABSTRACT The aim of this study was to investigate the association of baseline and changes of TyG‐BRI with incident CVD based on the UK Biobank and China Health and Retirement Longitudinal Study (CHARLS). A total of 418,510 and 7923 individuals from the UK Biobank and CHARLS were included in Analysis 1 (baseline TyG‐BRI with CVD risk).
Wen‐Yang Han +9 more
wiley +1 more source
Antihypertensive Treatment and Cancer: Umbrella Review of Meta-Analyses of Randomized Controlled Trials and Observational Studies. [PDF]
Rostami A +4 more
europepmc +1 more source

